The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
ID: 352285Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352285

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-117.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award (K22), a federal grant aimed at facilitating the transition of mentored, non-independent cancer researchers to independent faculty positions. This funding opportunity provides financial support for salary and research expenses for up to three years, encouraging early-career scientists to develop their independent research programs focused on cancer research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Hispanic-serving Institutions, and various community-based organizations, with applications opening on May 12, 2024, and a closing date of November 12, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-117.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-117-Full-Announcement.html
    PAR-24-117.html
    The NCI Transition Career Development Award (K22) is a funding opportunity by the National Cancer Institute (NCI) under the Department of Health and Human Services. This award aims to facilitate the transition of mentored, non-independent cancer researchers to independent faculty positions by providing financial support for salary and research expenses for up to three years. The program encourages early-career scientists to develop their independent research programs, with a strong emphasis on addressing cancer research needs. To be eligible, candidates should have a doctorate and at least two years but no more than eight years of postdoctoral training. Applications can be submitted starting May 12, 2024, with various review cycles and deadlines outlined. Each applicant must show the feasibility of their proposed research and commitment to a career in cancer research. The outlined criteria for review include the candidate’s experience, the career development plan, and the proposed research’s scientific merit. Institutions must demonstrate a commitment to supporting the candidate’s transition to independence. The framework provided in this announcement highlights the NIH's strategy to cultivate a diverse pool of scientists capable of advancing cancer research and improving public health.
    Similar Opportunities
    NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award to Promote Diversity (K22), a federal grant aimed at assisting postdoctoral fellows and individuals in equivalent positions from diverse backgrounds to transition into independent research roles in cancer research. This initiative seeks to enhance diversity within the NCI-funded cancer research workforce, specifically targeting groups underrepresented in the biomedical, behavioral, and clinical sciences, and provides up to three years of salary and research support for candidates who secure tenure-track faculty positions. The program emphasizes the importance of a diverse scientific team in addressing public health issues and requires applicants to have a terminal doctoral degree, a minimum of two years of postdoctoral training, and a clear mentorship structure, while excluding proposals that involve leading independent clinical trials. Interested applicants can find more information and apply before the closing date of January 7, 2025, by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visiting the opportunity's webpage at http://grants.nih.gov/grants/guide/pa-files/PAR-21-301.html.
    NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Career Transition Award (K22), a federal grant aimed at facilitating the transition of mentored postdoctoral researchers to tenure-track faculty positions while advancing the mission of the National Institute on Aging (NIA). This three-year grant provides salary and research support for candidates who secure a faculty position within 12 months of award approval, emphasizing the importance of a robust career development plan aligned with NIA's research priorities. The program underscores the government's commitment to fostering a diverse scientific workforce in health research, with eligibility extending to various institutions, including historically black colleges and universities and tribal colleges. Interested applicants must submit their proposals by November 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required), aimed at supporting postdoctoral fellows from underrepresented backgrounds in transitioning to independent research positions in cancer research. This grant provides "protected time" through salary and research support for three years, enabling candidates to lead an independent clinical trial or feasibility study while fostering diversity within the NCI-funded workforce. The program is crucial for addressing significant health disparities and encourages applications from historically underrepresented racial and ethnic groups, individuals with disabilities, and those from disadvantaged backgrounds. Interested applicants must adhere to the eligibility criteria outlined in the funding opportunity announcement, with applications due by January 7, 2025. For further inquiries, candidates can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Clinical Scientist Research Career Development Award (K08) to promote diversity in cancer research. This grant is aimed at individuals with clinical doctoral degrees from underrepresented backgrounds, providing them with protected research time and mentorship to enhance their capabilities in basic, behavioral, and translational cancer research. The program is designed to cultivate a diverse pool of qualified researchers to address the nation's health research needs and reduce disparities in cancer care and outcomes, with a maximum award duration of five years and a commitment of at least 75% of the candidate's time to career development activities. Interested applicants must submit their proposals by January 7, 2025, and can find additional information at the NIH grants website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00), aimed at supporting outstanding graduate students transitioning to independent cancer research careers. This grant provides a maximum of six years of funding, divided into one to two years for dissertation research and up to four years for postdoctoral training, specifically designed to enhance the capabilities of cancer research in the U.S. Eligible applicants include a diverse range of institutions, and the application process opened on October 17, 2023, with a submission deadline of November 19, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-042.html.
    Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Mentored Career Transition Award for NIMH Intramural Fellows (K22), designed to support the transition of qualified postdoctoral fellows from intramural research positions to tenure-track faculty roles at eligible U.S. institutions. This grant program consists of two mentored phases: an intramural phase lasting up to two years and an extramural phase lasting up to three years, aimed at fostering the development of independent research programs while allowing applicants to engage in clinical trials under mentorship. The award provides funding of up to $90,000 annually for PhD recipients and $100,000 for MD recipients, along with additional funds for research-related expenses, with a total project period not exceeding five years. Interested applicants can find more information and application guidelines at the NIH grants website, and should note that the application deadline is March 12, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Research Scientist Development Award to Promote Diversity (K01), a federal grant aimed at enhancing diversity within the cancer research workforce. This funding opportunity supports individuals from underrepresented backgrounds in biomedical and clinical sciences by providing salary and research support for a period of 3 to 5 years under the mentorship of experienced researchers, specifically for projects that do not involve leading independent clinical trials. The initiative is crucial for addressing disparities in cancer incidence and mortality rates among underserved populations, fostering a diverse pool of research talent, and promoting innovative solutions to complex health challenges. Interested applicants must submit their proposals by November 12, 2024, and can find additional information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Career Transition Award (K22), a federal grant aimed at supporting postdoctoral fellows in their transition to independent research positions, such as assistant professorships. This funding opportunity is specifically designed for applicants proposing research that does not involve leading independent clinical trials, although they may gain experience in existing clinical trials led by other investigators. The K22 award provides two years of funding, covering salary and research development costs, and is open to a diverse range of eligible applicants, including historically underrepresented institutions and organizations. Interested parties should note that the application deadline is January 7, 2025, and can find more information at the provided link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NHLBI Career Transition Award (K22), a federal grant aimed at supporting postdoctoral fellows and doctoral-level researchers transitioning from intramural NIH research to independent extramural research. This program features a two-phase support structure: an up to two-year mentored intramural phase followed by a three-year extramural phase, contingent upon a successful review of the awardee's research progress. The grant is designed to cultivate future researchers capable of addressing critical health-related questions and enhancing the scientific community, with an emphasis on diversity and inclusion of underrepresented groups. Interested applicants must have a relevant doctoral degree and adhere to stringent application instructions, with proposals due starting September 12, 2024. For further details, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and the opportunity is open until July 12, 2027.